{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:47:14Z","timestamp":1791319634973,"version":"4.3.1"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,10,27]]},"DOI":"10.18632\/oncotarget.5307","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T21:54:23Z","timestamp":1443563663000},"page":"34537-34548","source":"Crossref","is-referenced-by-count":12,"title":["Cytotoxic T cell responses are enhanced by antigen design involving the presentation of MUC1 peptide on cholera toxin B subunit"],"prefix":"10.18632","volume":"6","author":[{"given":"Wuguang","family":"Lu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China"},{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchong","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Yan","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cao","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Hu","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medical Science and Department of Pharmacology and Physiology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Medical Science and Department of Pharmacology and Physiology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Medical Science and Department of Pharmacology and Physiology, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Molecular Biology, Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China"},{"name":"Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxiu","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Microbial Metabolism, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, 200240, China"},{"name":"Engineering Research Center of Cell & Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai, 200240, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,9,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.4049\/jimmunol.170.5.2523","article-title":"Selective induction of high avidity CTL by altering the balance of signals from APC","volume":"170","author":"Berzofsky","year":"2003","journal-title":"Journal of immunology"},{"key":"2","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Restifo","year":"2004","journal-title":"Nature medicine"},{"key":"3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.mt.6300347","article-title":"Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells","volume":"16","author":"Wan","year":"2008","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"4","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.4049\/jimmunol.0802982","article-title":"IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity","volume":"182","author":"Overwijk","year":"2009","journal-title":"Journal of immunology"},{"key":"5","first-page":"2010","article-title":"Strategies for cancer vaccine development","author":"Tsang","year":"2010","journal-title":"Journal of biomedicine & biotechnology"},{"key":"6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0161-5890(94)90158-9","article-title":"Identification of potential CTL epitopes of tumor-associated antigen MAGE-1 for five common HLA-A alleles","volume":"31","author":"Livingston","year":"1994","journal-title":"Molecular immunology"},{"key":"7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/jcp.54.9.669","article-title":"Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer","volume":"54","author":"Knuth","year":"2001","journal-title":"Journal of clinical pathology"},{"key":"8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00002371-200403000-00006","article-title":"Immunologic analysis of a phase I\/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors","volume":"27","author":"Gueguen","year":"2004","journal-title":"Journal of immunotherapy"},{"key":"9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4161\/cbt.6.4.4201","article-title":"MUC1: a target molecule for cancer therapy","volume":"6","author":"Bandyopadhyay","year":"2007","journal-title":"Cancer biology & therapy"},{"key":"10","article-title":"MUC1 as a Potential Target in Anticancer Therapies","author":"Morris","year":"2013","journal-title":"American journal of clinical oncology"},{"key":"11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3892\/or.2013.2440","article-title":"Expression of human full-length MUC1 inhibits the proliferation and migration of a B16 mouse melanoma cell line","volume":"30","author":"Tai","year":"2013","journal-title":"Oncology reports"},{"key":"12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3835(94)03673-7","article-title":"The immunogenicity of MUC1 peptides and fusion protein","volume":"90","author":"McKenzie","year":"1995","journal-title":"Cancer letters"},{"key":"13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1073\/pnas.1115166109","article-title":"Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine","volume":"109","author":"Boons","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1467-7652.2011.00614.x","article-title":"Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice","volume":"9","author":"Mason","year":"2011","journal-title":"Plant biotechnology journal"},{"key":"15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/PL00006677","article-title":"MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines","volume":"48","author":"McKenzie","year":"2000","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"16","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1039\/c1cc13184b","article-title":"Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3\u2032-deoxy-3\u2032-fluoro-Thomsen-Friedenreich antigen","volume":"47","author":"Johannes","year":"2011","journal-title":"Chemical communications"},{"key":"17","first-page":"3315","article-title":"Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice","volume":"56","author":"Livingston","year":"1996","journal-title":"Cancer research"},{"key":"18","first-page":"1283","article-title":"Phase-I study of synthetic muc1 peptides in breast-cancer","volume":"6","author":"McKenzie","year":"1995","journal-title":"International journal of oncology"},{"key":"19","doi-asserted-by":"crossref","first-page":"33670","DOI":"10.1074\/jbc.271.52.33670","article-title":"A pathogen-specific epitope inserted into recombinant secretory immunoglobulin A is immunogenic by the oral route","volume":"271","author":"Kraehenbuhl","year":"1996","journal-title":"The Journal of biological chemistry"},{"key":"20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0264-410X(00)00267-X","article-title":"Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein","volume":"19","author":"Leclerc","year":"2000","journal-title":"Vaccine"},{"key":"21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/08830189409061720","article-title":"Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins","volume":"11","author":"Hofnung","year":"1994","journal-title":"International reviews of immunology"},{"key":"22","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1111\/j.1742-4658.2008.06646.x","article-title":"Creating hybrid proteins by insertion of exogenous peptides into permissive sites of a class A beta-lactamase","volume":"275","author":"Galleni","year":"2008","journal-title":"The FEBS journal"},{"key":"23","doi-asserted-by":"crossref","first-page":"17880","DOI":"10.1073\/pnas.1004728107","article-title":"Elicitation of structure-specific antibodies by epitope scaffolds","volume":"107","author":"Kwong","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"24","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.133.4.1818","article-title":"Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response","volume":"133","author":"Halsey","year":"1984","journal-title":"Journal of immunology"},{"key":"25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00262-010-0906-1","article-title":"Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model","volume":"59","author":"Mukherjee","year":"2010","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Lew","year":"1998","journal-title":"Journal of immunological methods"},{"key":"27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01357-5","article-title":"Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein\/transgenic mice","volume":"338","author":"Cribbs","year":"2003","journal-title":"Neurosci Lett"},{"key":"28","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/IAI.70.3.1260-1271.2002","article-title":"Mutational analysis of ganglioside GM(1)-binding ability, pentamer formation, and epitopes of cholera toxin B (CTB) subunits and CTB\/heat-labile enterotoxin B subunit chimeras","volume":"70","author":"Holmes","year":"2002","journal-title":"Infection and immunity"},{"key":"29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/eji.200535490","article-title":"Heat shock fusion protein induces both specific and nonspecific anti-tumor immunity","volume":"36","author":"Wang","year":"2006","journal-title":"European journal of immunology"},{"key":"30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1600-065X.1995.tb00077.x","article-title":"MUC-1 epithelial tumor mucin-based immunity and cancer vaccines","volume":"145","author":"Barratt-Boyes","year":"1995","journal-title":"Immunological reviews"},{"key":"31","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","article-title":"Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance","volume":"91","author":"Czerkinsky","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Advanced drug delivery reviews"},{"key":"33","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0264-410X(99)00526-5","article-title":"CpG DNA induces stronger immune responses with less toxicity than other adjuvants","volume":"18","author":"Davis","year":"2000","journal-title":"Vaccine"},{"key":"34","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1158\/0008-5472.CAN-11-3538","article-title":"The next challenge in cancer immunotherapy: controlling T-cell traffic to the tumor","volume":"72","author":"Abastado","year":"2012","journal-title":"Cancer research"},{"key":"35","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00262-010-0881-6","article-title":"CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection","volume":"59","author":"Nishimura","year":"2010","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"36","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Thornton","year":"1993","journal-title":"Journal of Applied Crystallography"},{"key":"37","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1038\/ncomms5189","article-title":"Relative motions between left flipper and dorsal fin domains favour P2X4 receptor activation","volume":"5","author":"Yu","year":"2014","journal-title":"Nature communications"},{"key":"38","unstructured":"Schrodinger. The PyMOL Molecular Graphics System, Version 1. 2010; 3r1."},{"key":"39","first-page":"173","article-title":"An improved protocol for coupling synthetic peptides to carrier proteins for antibody production using DMF to solubilize peptides","volume":"18","author":"Lee","year":"2007","journal-title":"Journal of biomolecular techniques: JBT"},{"key":"40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2014.12.039","article-title":"Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy","volume":"200","author":"Liu","year":"2015","journal-title":"Journal of controlled release: official journal of the Controlled Release Society"},{"key":"41","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1182\/blood.V96.9.3102","article-title":"Induction of cytotoxic T-lymphocyte responsesafter vaccinations with peptide-pulsed dendritic cells","volume":"96","author":"Brugger","year":"2000","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T18:40:27Z","timestamp":1692038427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.5307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,21]]},"references-count":41,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,10,27]]}},"alternative-id":["5307","26417929"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.5307","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,21]]}}}